Ironwood Pharmaceuticals to Host Webinar on Accounting Treatment for LINZESS™ (Linaclotide)

  Ironwood Pharmaceuticals to Host Webinar on Accounting Treatment for
  LINZESS™ (Linaclotide)

Business Wire

CAMBRIDGE, Mass. -- November 01, 2012

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will be
hosting a webinar to provide an overview of how LINZESS will be reflected in
Ironwood’s quarterly income statements following its commercial availability
in the U.S. Ironwood will co-commercialize the product in the U.S. through its
collaboration with Forest Laboratories, Inc.

The webinar will take place on Tuesday, November 6, 2012 at 12:00 p.m. Eastern
Time. Individuals interested in participating in the webinar should visit the
Investors section of Ironwood’s website at; please log
on at least 15 minutes prior to the start of the event to ensure adequate time
for any software downloads that may be required. For listen-only
participation, the webinar can also be accessed by dialing (866) 437-1772
(U.S. and Canada) or (973) 638-3229 (international) and use the conference ID
number 45259150.

A replay of the webinar will be available on Ironwood’s website or via
telephone starting November 6, 2012 at approximately 3:00 p.m. Eastern Time,
running through 11:59 p.m. Eastern Time on November 13, 2012. To listen to the
replay by phone, dial (855) 859-2056 (U.S. and Canada) or (404) 537-3406
(international) and use conference ID number 45259150.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical
company dedicated to the art and science of great drugmaking. Ironwood is
located in Cambridge, Mass. To learn more, visit


Ironwood Pharmaceuticals, Inc.
Media Relations
Lisa Buffington, 617-374-5103
Vice President, Corporate Communications
Investor Relations
Meredith Kaya, 617-374-5082
Associate Director, Investor Relations
Press spacebar to pause and continue. Press esc to stop.